Nayak Sanjay
SEC CIK 2012715 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | Chief Strategy Off | 326.9K | — | $261.5K | 14 | 2024-02-22 | 2026-08-24 |
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-26 17:58 | 2026-08-24 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $10.78 | -1,897 | 326.9K | -0.6% | -$20.4K |
| T | 2026-05-28 16:05 | 2026-05-26 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $8.20 | -1,858 | 328.8K | -0.6% | -$15.2K |
| 2026-02-25 | 2026-02-23 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $8.28 | -1,759 | 330.7K | -0.5% | -$14.6K | |
| 2026-02-17 | 2026-02-12 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $9.04 | -10.3K | 332.4K | -3% | -$93.5K | |
| D | 2026-01-06 | 2026-01-02 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +64.9K | 342.8K | +23% | $0 |
| 2025-11-26 | 2025-11-24 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $12.04 | -1,878 | 277.9K | -0.7% | -$22.6K | |
| 2025-08-27 | 2025-08-25 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $12.04 | -1,885 | 279.7K | -0.7% | -$22.7K | |
| 2025-05-27 | 2025-05-23 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $7.17 | -1,862 | 281.6K | -0.7% | -$13.4K | |
| 2025-02-26 | 2025-02-24 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $6.84 | -1,895 | 283.5K | -0.7% | -$13.0K | |
| D | 2025-02-13 | 2025-02-11 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +111.0K | 285.4K | +64% | $0 |
| 2024-11-27 | 2024-11-25 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $9.00 | -1,814 | 174.4K | -1% | -$16.3K | |
| 2024-08-27 | 2024-08-23 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $9.02 | -1,832 | 176.2K | -1% | -$16.5K | |
| 2024-05-28 | 2024-05-23 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | S - Sale | $5.84 | -2,274 | 178.0K | -1% | -$13.3K | |
| D | 2024-02-26 | 2024-02-22 | OCUL | OCULAR THERAPEUTIX, INC | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +80.3K | 180.3K | +80% | $0 |
Purchase Sale Sale after option exercise All abbreviations